[
    {
        "molecule_name": "antibodies, e.g., monoclonal antibodies",
        "protein_target_name": "canine PD-1",
        "protein_uniprot_id": null,
        "protein_seq_id": "103",
        "binding_metric": "Kd",
        "value": "1X 10^-5 To 1X 10^-12",
        "unit": "M",
        "raw_mentions": "In addition, the invention provides antibodies, e.g., monoclonal antibodies, against canine PD-1 comprising variants of the CDRs of the invention having the corresponding canonical structures provided herein and binding to the amino acid sequence of SEQ ID NO: 103. \nIn such embodiments, the dissociation constant (Kd) for antibody-canine PD-1 binding is 1X 10<sup>-5</sup>To 1X 10<sup>-12 </sup>And M."
    },
    {
        "molecule_name": "M",
        "protein_target_name": "canine PD-1",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "dissociation constant",
        "value": "1X 10^-5 M to 1X 10^-12 M",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-5 </sup>M to 1X 10<sup>-12 </sup>M, the dissociation constant of M binds to canine PD-1.\nIn more specific embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-7 </sup>M to 1X 10<sup>-11 </sup>M, the dissociation constant of M binds to canine PD-1.\nIn still more particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-8 </sup>M to 1X 10<sup>-11 </sup>M, the dissociation constant of M binds to canine PD-1.\nIn still more particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-8 </sup>M to 1X 10<sup>-10 </sup>M, the dissociation constant of M binds to canine PD-1.\nIn particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>2 </sup>M<sup>-1</sup>s<sup>-1</sup> to 1X 10<sup>7 </sup>M<sup>-1</sup>s<sup>-1</sup> binds to canine PD-1.\nIn more specific embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>3 </sup>M<sup>-1</sup>s<sup>-1</sup> to 1X 10<sup>6</sup>M<sup>-1</sup>s<sup>-1</sup> binds to canine PD-1.\nIn a more specific embodiment, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>3 </sup>M<sup>-1</sup>s<sup>-1</sup> to 1X 10<sup>5</sup>M<sup>-1</sup>s<sup>-1</sup> binds to canine PD-1.\nIn still more particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>4 </sup>M<sup>-1</sup>s<sup>-1</sup> to 1X 10<sup>5</sup>M<sup>-1</sup>s<sup>-1</sup> binds to canine PD-1.\nIn particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-3</sup>s<sup>-1</sup> to 1X 10<sup>-8 </sup>s<sup>-1</sup> binds to canine PD-1.\nIn more specific embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-4</sup> s<sup>-1</sup> to 1X 10<sup>-7 </sup>s<sup>-1</sup> binds to canine PD-1.\nIn still more particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-5</sup> s<sup>-1</sup> to 1X 10<sup>-7 </sup>s<sup>-1</sup> binds to canine PD-1."
    },
    {
        "molecule_name": "M",
        "protein_target_name": "canine PD-1",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "dissociation constant",
        "value": "1X 10^-7 M to 1X 10^-11 M",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-5 </sup>M to 1X 10<sup>-12 </sup>M, the dissociation constant of M binds to canine PD-1.\nIn more specific embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-7 </sup>M to 1X 10<sup>-11 </sup>M, the dissociation constant of M binds to canine PD-1.\nIn still more particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-8 </sup>M to 1X 10<sup>-11 </sup>M, the dissociation constant of M binds to canine PD-1.\nIn still more particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-8 </sup>M to 1X 10<sup>-10 </sup>M, the dissociation constant of M binds to canine PD-1.\nIn particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>2 </sup>M<sup>-1</sup>s<sup>-1</sup> to 1X 10<sup>7 </sup>M<sup>-1</sup>s<sup>-1</sup> binds to canine PD-1.\nIn more specific embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>3 </sup>M<sup>-1</sup>s<sup>-1</sup> to 1X 10<sup>6</sup>M<sup>-1</sup>s<sup>-1</sup> binds to canine PD-1.\nIn a more specific embodiment, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>3 </sup>M<sup>-1</sup>s<sup>-1</sup> to 1X 10<sup>5</sup>M<sup>-1</sup>s<sup>-1</sup> binds to canine PD-1.\nIn still more particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>4 </sup>M<sup>-1</sup>s<sup>-1</sup> to 1X 10<sup>5</sup>M<sup>-1</sup>s<sup>-1</sup> binds to canine PD-1.\nIn particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-3</sup>s<sup>-1</sup> to 1X 10<sup>-8 </sup>s<sup>-1</sup> binds to canine PD-1.\nIn more specific embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-4</sup> s<sup>-1</sup> to 1X 10<sup>-7 </sup>s<sup>-1</sup> binds to canine PD-1.\nIn still more particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-5</sup> s<sup>-1</sup> to 1X 10<sup>-7 </sup>s<sup>-1</sup> binds to canine PD-1."
    },
    {
        "molecule_name": "M",
        "protein_target_name": "canine PD-1",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "dissociation constant",
        "value": "1X 10^-8 M to 1X 10^-11 M",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-5 </sup>M to 1X 10<sup>-12 </sup>M, the dissociation constant of M binds to canine PD-1.\nIn more specific embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-7 </sup>M to 1X 10<sup>-11 </sup>M, the dissociation constant of M binds to canine PD-1.\nIn still more particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-8 </sup>M to 1X 10<sup>-11 </sup>M, the dissociation constant of M binds to canine PD-1.\nIn still more particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-8 </sup>M to 1X 10<sup>-10 </sup>M, the dissociation constant of M binds to canine PD-1.\nIn particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>2 </sup>M<sup>-1</sup>s<sup>-1</sup> to 1X 10<sup>7 </sup>M<sup>-1</sup>s<sup>-1</sup> binds to canine PD-1.\nIn more specific embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>3 </sup>M<sup>-1</sup>s<sup>-1</sup> to 1X 10<sup>6</sup>M<sup>-1</sup>s<sup>-1</sup> binds to canine PD-1.\nIn a more specific embodiment, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>3 </sup>M<sup>-1</sup>s<sup>-1</sup> to 1X 10<sup>5</sup>M<sup>-1</sup>s<sup>-1</sup> binds to canine PD-1.\nIn still more particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>4 </sup>M<sup>-1</sup>s<sup>-1</sup> to 1X 10<sup>5</sup>M<sup>-1</sup>s<sup>-1</sup> binds to canine PD-1.\nIn particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-3</sup>s<sup>-1</sup> to 1X 10<sup>-8 </sup>s<sup>-1</sup> binds to canine PD-1.\nIn more specific embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-4</sup> s<sup>-1</sup> to 1X 10<sup>-7 </sup>s<sup>-1</sup> binds to canine PD-1.\nIn still more particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-5</sup> s<sup>-1</sup> to 1X 10<sup>-7 </sup>s<sup>-1</sup> binds to canine PD-1."
    },
    {
        "molecule_name": "M",
        "protein_target_name": "canine PD-1",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "dissociation constant",
        "value": "1X 10^-8 M to 1X 10^-10 M",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-5 </sup>M to 1X 10<sup>-12 </sup>M, the dissociation constant of M binds to canine PD-1.\nIn more specific embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-7 </sup>M to 1X 10<sup>-11 </sup>M, the dissociation constant of M binds to canine PD-1.\nIn still more particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-8 </sup>M to 1X 10<sup>-11 </sup>M, the dissociation constant of M binds to canine PD-1.\nIn still more particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-8 </sup>M to 1X 10<sup>-10 </sup>M, the dissociation constant of M binds to canine PD-1.\nIn particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>2 </sup>M<sup>-1</sup>s<sup>-1</sup> to 1X 10<sup>7 </sup>M<sup>-1</sup>s<sup>-1</sup> binds to canine PD-1.\nIn more specific embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>3 </sup>M<sup>-1</sup>s<sup>-1</sup> to 1X 10<sup>6</sup>M<sup>-1</sup>s<sup>-1</sup> binds to canine PD-1.\nIn a more specific embodiment, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>3 </sup>M<sup>-1</sup>s<sup>-1</sup> to 1X 10<sup>5</sup>M<sup>-1</sup>s<sup>-1</sup> binds to canine PD-1.\nIn still more particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>4 </sup>M<sup>-1</sup>s<sup>-1</sup> to 1X 10<sup>5</sup>M<sup>-1</sup>s<sup>-1</sup> binds to canine PD-1.\nIn particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-3</sup>s<sup>-1</sup> to 1X 10<sup>-8 </sup>s<sup>-1</sup> binds to canine PD-1.\nIn more specific embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-4</sup> s<sup>-1</sup> to 1X 10<sup>-7 </sup>s<sup>-1</sup> binds to canine PD-1.\nIn still more particular embodiments, the mammalian antibody or antigen-binding fragment thereof is expressed as 1X 10<sup>-5</sup> s<sup>-1</sup> to 1X 10<sup>-7 </sup>s<sup>-1</sup> binds to canine PD-1."
    },
    {
        "molecule_name": "canine PD-1",
        "protein_target_name": "canine PD-1",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "subnanomolar",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nThe dissociation time was 1200 seconds and the concentrations were 50, 100, 200 (x2) 400 and 800 nanomolar (nM).\nAntigen (canine PD-1) was immobilized on the sensor chip by amine coupling, and four antibodies as indicated in table 5 below were used as analytes flowing over the antigen surface. The results demonstrate that the binding avidity of the anti-canine PD-1 antibodies of the invention for canine PD-1 antigen is strong, with nanomolar and even subnanomolar dissociation constants (Kd).\nA 3-fold serial dilution was made of a solution of anti-cPD 1 mAb in CHO medium (starting at 30 μ g/mL) \n50 μ L/well cPD-L1-Fc-biotin (2 μ g/ml in CHO medium stock) was added \n TABLE 5 was not fully provided, so no rows can be extracted from it."
    }
]